Maze Therapeutics, Inc. (Nasdaq: MAZE), a clinical-stage biopharmaceutical company harnessing the power of human genetics to ...

A New Hampshire man fought for the chance at a pig kidney transplant, spending months getting into good enough shape to be ...

For the second time in less than a year, doctors at Massachusetts General Hospital have transplanted a genetically-edited pig ...

Millions of people worldwide take proton pump inhibitors (PPIs) to relieve heartburn, acid reflux, and gastroesophageal ...

Millions of people around the world take medication to control high blood pressure, a condition that increases the risk of heart attacks, strokes, and kidney disease. Doctors often prescribe a pill ...

(WIB) – Advances in medical treatment for cardiovascular disease, a leading cause of death in the U.S., have helped patients live longer. But a new report finds that risk factors that lead to heart ...

A personalized neoantigen cancer vaccine generated strong immune responses in renal cell carcinoma patients, leading to ...

The FDA will allow two biotechnology companies to run clinical trials: United Therapeutics and eGenesis. United Therapeutics ...

GLP-1 medications are renowned for their ability to treat type 2 diabetes and aid weight loss. Now, there's a new benefit to ...

BURLINGTON, N.C. — Albert Jefferies, better known as Al J, met up with his kidney donor, Mandy Harris, following his ...

A small, early trial of a vaccine that mobilizes the immune system to battle advanced kidney cancers appears successful, ...

Ozempic has been approved to reduce the risk of worsening kidney disease and cardiovascular death in adults with Type 2 ...